Arrowhead Pharmaceuticals (ARWR) Long-Term Debt Repayments (2011 - 2026)
Arrowhead Pharmaceuticals' Long-Term Debt Repayments was $33.39 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 33.2% from $50 million a year earlier but up 87.5% from the prior quarter.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Long-Term Debt Repayments (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Arrowhead Pharmaceuticals' Long-Term Debt Repayments was $117.89 million through Jun 30, 2026, down 41.5% year-over-year; for FY2025 (ended Sep 30, 2025), it was $201.63 million.
- Quarterly Long-Term Debt Repayments has moved between $17.81 million (fiscal Q2 2026) and $151.63 million (fiscal Q2 2025) over five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 8.47 Bn | 3.24 Bn | - | 33.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.39 Mn |
| Mar 31, 2026 | 17.81 Mn |
| Dec 31, 2025 | 66.70 Mn |
| Jun 30, 2025 | 50.00 Mn |
| Mar 31, 2025 | 151.63 Mn |
| Sep 30, 2019 | -150.00 |
| Mar 31, 2019 | 1.00 |
| Dec 31, 2018 | 2.42 Mn |
| Sep 30, 2018 | 53,520.00 |
| Jun 30, 2018 | 52,580.00 |
| Mar 31, 2018 | -95,384.00 |
| Dec 31, 2017 | 197,790.00 |
| Sep 30, 2017 | 100,645.00 |
| Mar 31, 2017 | 49,868.00 |
| Dec 31, 2016 | 47,277.00 |
| Sep 30, 2016 | 54,725.00 |
| Jun 30, 2016 | 54,498.00 |
| Mar 31, 2016 | 54,275.00 |
| Dec 31, 2015 | 54,051.00 |
| Sep 30, 2015 | 53,829.00 |
API Access
Arrowhead Pharmaceuticals Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();